AB142141
iCRT5, CRT Inhibitor, CRT inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 367.44 g/mol, Purity >98%. Cell-permeable β-catenin-responsive transcription (CRT) inhibitor. Wnt responsive STF16 luciferase inhibitor (IC50 = 18 nM). Active in vitro.
1 Images
- Chemical Structure
Lab
Chemical Structure - iCRT5, CRT Inhibitor, CRT inhibitor (AB142141)
2D chemical structure image of ab142141, iCRT5, CRT Inhibitor, CRT inhibitor
Product details
This product is manufactured by BioVision, an Abcam company and was previously called 1896 CRT Inhibitor, iCRT5. 1896-25 is the same size as the 25 mg size of ab142141.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 22:647 PubMed39434141
2024
Co-delivery of polyphyllin II and IR780 PLGA nanoparticles induced pyroptosis combined with photothermal to enhance hepatocellular carcinoma immunotherapy.
Applications
Unspecified application
Species
Unspecified reactive species
Huating Huang,Jing Fu,Hulinyue Peng,Yuanyuan He,Aqian Chang,Huizhong Zhang,Yang Hao,Xiaohan Xu,Shiman Li,Jingxia Zhao,Jian Ni,Xiaoxv Dong
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com